A compound semaglutide pharmacy mixes its own versions of the drug. Learn how these pharmacies work, dosing, legal status, safety, and what to verify.
A compound semaglutide pharmacy is a licensed compounding facility that prepares its own semaglutide from bulk active ingredient instead of dispensing FDA-approved brand products such as Ozempic, Wegovy, or Rybelsus. These pharmacies are regulated mainly by state boards of pharmacy and by Section 503A or 503B of the federal Food, Drug, and Cosmetic Act. Their semaglutide is not FDA-approved, so it has not been reviewed for safety, effectiveness, or manufacturing quality the way brand-name drugs have.
What a Compounding Pharmacy Does With Semaglutide
Compounding exists so a pharmacist can tailor a medication for a patient who cannot use a standard product — for example, someone who needs a different strength or a needle-free option. With semaglutide, compounded products are usually sold as a lyophilized powder the patient reconstitutes, a pre-filled syringe, or an oral liquid.
That flexibility is also the weak point. Because these are custom preparations, strength, purity, and storage conditions can differ from one pharmacy to the next and from one batch to the next.
- Vials of powder plus diluent for self-mixing
- Pre-filled pens or insulin-style injection devices
- Single-dose syringes
- Oral drops, sublingual liquids, or capsules
Why People Search for a Compound Semaglutide Pharmacy
Demand for compounded GLP-1 medicines grew for a few practical reasons, and cost tops the list.
- Price: FDA-approved semaglutide products list at roughly $900 to $1,350 per month without insurance.
- Supply: Manufacturing shortages pushed patients toward alternatives.
- Dosing flexibility: Some prescribers want to start below the smallest branded dose.
- Access: Telehealth visits make it easier to get a prescription in some states.
Compounded vs. FDA-Approved Semaglutide
| Factor | Compounded semaglutide | FDA-approved semaglutide |
|---|---|---|
| FDA review | Not FDA-approved; no agency review of safety, efficacy, or quality | Approved as Ozempic, Wegovy, and Rybelsus |
| Ingredient source | Bulk API from a supplier the pharmacy chooses | Manufacturer-controlled, tested formulation |
| Dosing forms | Vials, syringes, drops, capsules | Pre-filled pens and oral tablets |
| Typical monthly cost | Often $100 to $400 | $900 to $1,350 list price |
| Insurance coverage | Usually not covered | Often covered for approved indications |
| Supply consistency | Depends on the pharmacy's API supply | Depends on the manufacturer |
Semaglutide Compound Dosage and Forms
There is no single standard semaglutide compound dosage, because each pharmacy mixes its own concentration and each prescriber writes a different titration schedule. Most protocols start low — the equivalent of 0.25 mg once weekly — and step up every four weeks, mirroring the branded titration.
Because concentrations vary, never switch products and keep injecting the same number of units on the syringe without recalculating. A volume that delivers 0.25 mg from one pharmacy's vial can deliver a very different amount from another's.
Reported compound semaglutide doses have ranged from about 0.1 mg to 2.4 mg weekly, and some oral forms are dosed daily. Ask the pharmacist to state the concentration in milligrams per milliliter in writing before you start.
The Compound Semaglutide Ban and Today's Legal Status
In February 2025, the FDA declared the semaglutide shortage resolved. Once a shortage ends, compounders generally may not make what the agency calls an essentially a copy of a commercially available drug, and the FDA set staggered enforcement dates for 503A and 503B pharmacies in the spring of 2025.
Litigation followed, and the rules have continued to shift. A compound semaglutide ban is not one simple nationwide prohibition: what is permitted depends on the date, the pharmacy's registration type, state law, and whether a prescriber documents a clinical reason the patient cannot use an approved product. Check the FDA's current guidance and your state board of pharmacy before ordering.
Safety and Side Effects
Compounded and brand-name semaglutide share the same class effects. Common compound semaglutide side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and injection-site reactions, and most of these ease after a few weeks.
More serious risks include pancreatitis, gallbladder disease, dehydration from persistent vomiting, and low blood sugar when semaglutide is combined with insulin or sulfonylureas. The drug also carries a boxed warning for thyroid C-cell tumors seen in rodents, and it is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2.
Anyone considering glp-1 compound semaglutide products should have a licensed prescriber involved rather than self-dosing from an online questionnaire, and any severe or persistent symptom deserves a call to a clinician.
How to Vet a Compounding Pharmacy
- Confirm the pharmacy holds a license in your state and know whether it is a 503A or 503B facility (503B outsourcing facilities appear on the FDA's registered list).
- Request a certificate of analysis for both the raw API and the finished preparation, including potency and sterility testing.
- Verify sterile compounding compliance, such as USP <797> standards, and confirm the product is dispensed only with a prescription.
- Ask who handles safety questions and whether a pharmacist is reachable by phone.
- Walk away if a seller ships semaglutide without a prescription, quotes a research-chemical price, or will not name its API supplier.
Names such as Strive Pharmacy, Hallandale Pharmacy, and Empower Pharmacy come up often in patient communities, and each is a state-licensed compounding operation. A recognizable name is still not proof that a specific semaglutide product is lawful to dispense on a given day or appropriate for your situation.
The Bottom Line
A compound semaglutide pharmacy can offer a lower-cost, more flexible option when an FDA-approved product is unavailable, unaffordable, or unsuitable. The tradeoff is real: the compounded drug itself is not FDA-approved, and quality depends heavily on the individual pharmacy.
Talk with a healthcare professional before starting, write down your concentration and dose in milligrams, and re-check the current legal status of compounded semaglutide before you pay.
Frequently Asked Questions
Is compounded semaglutide still legal in the United States?
It depends on the pharmacy, the state, and the current date. After the FDA declared the semaglutide shortage resolved in February 2025, compounding copies of Ozempic and Wegovy became subject to enforcement deadlines, and the rules have been contested in court since. Some pharmacies still compound semaglutide when a prescriber documents a clinical reason the patient cannot use an approved product, so verify the latest FDA guidance and your state board's position before ordering.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Both contain semaglutide as the active ingredient, but compounded versions are custom preparations that the FDA has not reviewed for safety, effectiveness, or quality, and strength varies by pharmacy. Ozempic, Wegovy, and Rybelsus are FDA-approved products with standardized manufacturing, dosing, and labeling. Because concentrations differ, never assume a compounded dose converts one-to-one with a branded pen.
How do I know if a compound semaglutide pharmacy is legitimate?
A legitimate compounding pharmacy is licensed in your state, requires a valid prescription, and can provide a certificate of analysis covering the active ingredient and the finished product. If it is a 503B outsourcing facility, it should appear on the FDA's registered facility list, and it should follow sterile compounding standards. Be skeptical of any seller that ships semaglutide without a prescription or markets it as a research chemical.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.